"Cancers survival" trang 1 - tải miễn phí từ tailieunhanh
Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: A SEER population-based analysis

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: A SEER population-based analysis
7    47    1
Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers
11    46    1
Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts diseasefree and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression

Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts diseasefree and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression
11    53    1
Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: A retrospective study

Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: A retrospective study
12    36    1
NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
9    43    1
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: Updated results from a phase 3 trial

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: Updated results from a phase 3 trial
7    50    2
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study
13    29    1
Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases

Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases
6    11    1
The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates

The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
13    5    1
Comparison of survival of patients with metastases from known versus unknown primaries: Survival in metastatic cancer

Comparison of survival of patients with metastases from known versus unknown primaries: Survival in metastatic cancer
8    51    1
A clinicopathological study and survival analysis of 99 breast cancers with HER2/ CEP17 ratio≥2.0 and an average HER2 copy number

A clinicopathological study and survival analysis of 99 breast cancers with HER2/ CEP17 ratio≥2.0 and an average HER2 copy number
13    3    1
PODXL might be a new prognostic biomarker in various cancers: A metaanalysis and sequential verification with TCGA datasets

PODXL might be a new prognostic biomarker in various cancers: A metaanalysis and sequential verification with TCGA datasets
13    52    1
Radiomics-based prediction of response to immune checkpoint inhibitor treatment for solid cancers using computed tomography: A real-world study of two centers

Radiomics-based prediction of response to immune checkpoint inhibitor treatment for solid cancers using computed tomography: A real-world study of two centers
11    5    1
Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers

Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers
8    28    1
Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome

Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome
10    47    1
Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival

Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival
10    43    1
INHBA is a prognostic predictor for patients with colon adenocarcinoma

INHBA is a prognostic predictor for patients with colon adenocarcinoma
10    88    0
Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers

Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers
14    74    0
The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients

The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients
8    72    0
STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers

STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
14    84    0